s6y
Company name or ticker
Search
Sarepta Therapeutics, Inc.
4
Chambers Michael Andrew: Statement of changes in beneficial ownership of securities
Filed
Tuesday, August 15, 2023
Period
Aug 14, 2023
Accession number
0001209191-23-045766
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header